Hyundai IPO subscribed 18% on Day 1; LIC MF reduces minimum SIP limits

Hyundai IPO subscribed 18% on Day 1; LIC MF reduces minimum SIP limits



Hyundai Motor India garnered 18 per cent subscription on Tuesday, the opening day of the issue. The offering received bids for 17.81 million shares—three-fourths of which came from retail investors—as against 99.77 million on offer. A day earlier, Hyundai Motor had allotted 42.4 million shares worth Rs 8,315 crore to anchor investors at Rs 1,960 apiece, the higher end of its price band. The price range for the issue is Rs 1,865-Rs 1,960 per share, which values the country’s second-largest passenger car maker at Rs 1.51 trillion-Rs 1.59 trillion. Hyundai’s IPO closes on Thursday.


LIC MF reduces minimum SIP limits

Click here to connect with us on WhatsApp

 


LIC Mutual Fund on Tuesday announced a reduction in its systematic investment plan (SIP) amount with effect from October 16. The fund house has reduced daily SIP to Rs 100 and in multiples of Rs 1 thereafter for select schemes, while the monthly SIP limit has been reduced to Rs 200. Further, the quarterly SIP limit has also been brought down to Rs 1,000 for select schemes. The decision follows the market regulator Sebi’s push for bite-size SIPs or “sachetisation” of financial products for wider reach. “The launch of small-ticket SIPs will enable healthy participation of retail investors into mutual funds from smaller cities and towns to further drive financial inclusion across the country,” said RK Jha, managing director and chief executive officer, LIC Mutual Fund.


Angel One jumps 18% from strong Q2 show


Shares of Angel One rose over 18 per cent on Tuesday after the company’s second-quarter earnings surpassed Street expectations on the back of operational efficiencies. The stock ended at Rs 3,222, valuing the discount broker at Rs 29,000 crore. The company’s net profit for the quarter ended September 2024 rose 45 per cent quarter-on-quarter (Q-o-Q) to Rs 423 crore on total income of Rs 1,516 crore, which was up 7.5 per cent Q-o-Q. Angel One’s client base rose 11 per cent Q-o-Q to 27.5 million, while the number of orders rose 5.8 per cent to 489 million.


Garuda Construction gains 12% on debut


Shares of Garuda Construction and Engineering ended with a 12.5 per cent gain on Tuesday. After hitting a high of Rs 121 and a low of Rs 100, the stock ended at Rs 107, up Rs 12 over its issue price of Rs 95. Garuda’s Rs 264-crore IPO was subscribed over seven times. At the last close, the company was valued at Rs 994 crore. Founded in 2010, Garuda is primarily focused on the construction of residential and commercial buildings. The company also plans to venture into industrial and infrastructure projects.


Sebi revises position limits in the equity derivative segment


The Securities and Exchange Board of India (Sebi) on Tuesday revised the norms on monitoring of position limits for equity derivative segment. Position limits are specified to curb any manipulation or misuse owing to a significant ownership of derivative contracts by the stock brokers of traders. “The position limits for TMs (trading members), cumulatively for client and proprietary trades, in index Futures and Options contracts may be set at higher of Rs 7,500 crore or 15 per cent of the total OI (open interest) in the market,” noted the fresh circular. Till now this threshold was kept at Rs 500 crore or 15 per cent of the total OI. The changes were brought after discussion with the secondary market advisory committee and will be effective immediately. 

First Published: Oct 15 2024 | 6:29 PM IST



Source link

India market regulator raises F&O position limits for trading members

India market regulator raises F&O position limits for trading members


SEBI

This limit was earlier set at the higher of 5 billion rupees or 15% of the total open interest. (Photo: Shutterstock)


India’s market regulator on Thursday said it will raise the position limit for trading members in the futures and options segment.


The overall position limit, including client and proprietary trades, will be set at 75 billion rupees ($892.73 million) or 15% of the total open interest in the market, whichever is higher, the Securities and Exchange Board of India said in a notification.

Click here to connect with us on WhatsApp


This limit was earlier set at the higher of 5 billion rupees or 15% of the total open interest.


The position limits will be applicable for index futures and index options separately as it is the current practice, Sebi said.

 


The provisions come into effect immediately.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

First Published: Oct 15 2024 | 6:22 PM IST



Source link

SEBI raises position limits for index derivatives

SEBI raises position limits for index derivatives


The Securities and Exchange Board of India (SEBI) has announced changes to position limits and monitoring practices for equity derivatives, particularly index futures and options contracts.

Effective immediately, SEBI has increased the position limits for trading members (TMs) in index derivatives. The new limit is set at the higher of Rs 7,500 crore or 15% of the total Open Interest (OI) in the market, up from the previous limit of Rs 500 crore or 15% of total OI. The position limits will be applicable for index futures and index options separately.

Starting from April 1, 2025, SEBI will begin monitoring positions based on the total open interest of the market at the end of the previous day’s trade. This shift from real-time monitoring aligns with the current practice in the currency derivatives segment and aims to address concerns about fluctuations in open interest throughout the trading day.

Click here to connect with us on WhatsApp

 

SEBI has clarified that participants will not be penalized or forced to unwind their positions in cases where the market Open Interest drops compared to the previous day, even if their position remains unchanged. This is to prevent “passive breaches” of the new position limits.

Stock exchanges and clearing corporations are required to modify their bye-laws and regulations to implement these changes. Market participants, including trading members, are advised to review the SEBI circular and familiarize themselves with the new guidelines.

Powered by Capital Market – Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Oct 15 2024 | 6:20 PM IST



Source link

SEBI raises position limits for index derivatives

SG Finserve standalone net profit declines 19.27% in the September 2024 quarter


Sales decline 29.59% to Rs 30.89 crore

Net profit of SG Finserve declined 19.27% to Rs 14.12 crore in the quarter ended September 2024 as against Rs 17.49 crore during the previous quarter ended September 2023. Sales declined 29.59% to Rs 30.89 crore in the quarter ended September 2024 as against Rs 43.87 crore during the previous quarter ended September 2023.

ParticularsQuarter EndedSep. 2024Sep. 2023% Var.Sales30.8943.87 -30 OPM %67.3486.41 PBDT20.8023.31 -11 PBT20.6823.28 -11 NP14.1217.49 -19

Powered by Capital Market – Live News

Click here to connect with us on WhatsApp

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Oct 15 2024 | 6:01 PM IST



Source link

Senores Pharmaceuticals, Sagility India get Sebi's go ahead to float IPOs

Senores Pharmaceuticals, Sagility India get Sebi's go ahead to float IPOs


ipo market listing share market

Sagility India’s proposed IPO is entirely an OFS of 98.44 crore shares by promoter Sagility BV, according to the Draft Red Herring Prospectus (DRHP).


Senores Pharmaceuticals Ltd and Sagility India Ltd, a technology-enabled services provider in the healthcare services space, have received Sebi’s go ahead to float their Initial Public Offerings (IPOs), an update with the markets regulator showed on Tuesday.


On the other hand, the regulator has returned the rights issue document of The Bombay Dyeing and Manufacturing Company Ltd , the update showed.

Click here to connect with us on WhatsApp


The development from the Securities and Exchange Board of India (Sebi) came a year after the company submitted its draft papers in October 2022 to the regulator proposing to raise Rs 940 crore through the rights issue.

 


Both Senores Pharmaceuticals and Sagility had filed their respective draft documents in July seeking the regulator’s nod to launch IPOs. The regulator’s observation was issued on October 9, the update showed.


In Sebi’s parlance, obtaining its observations means go-ahead to launch the public issues.


As per the draft paper, Senores Pharmaceuticals’ IPO is a combination of fresh issuance of shares worth Rs 500 crore and an offer for sale (OFS) of up to 27 lakh equity shares by promoters and other selling shareholders.


Proceeds from the Ahmedabad-based company’s fresh issuance will be utilised for setting up a manufacturing facility for the production of sterile injections in its Atlanta facility; funding the working capital requirements of the company and its subsidiaries; supporting inorganic growth through acquisition and other strategic initiatives and payment of debt. Besides, a portion will be used for general corporate purposes.


Senores Pharmaceuticals specialises in identifying, developing, and manufacturing a wide array of speciality and complex pharmaceutical products. The company had launched 54 products in major therapeutic segments, including antibiotics, anti-bacterial, anti-fungal and bloodline as of March this year.


Sagility India’s proposed IPO is entirely an OFS of 98.44 crore shares by promoter Sagility BV, according to the Draft Red Herring Prospectus (DRHP).


Since it is an OFS, the Bengaluru-based company will not receive any proceeds from the public issue, and the entire fund will go to the selling shareholders.


The company provides technology-driven services to both payers (US health insurance companies, which finance and reimburse the cost of health services), and providers (primarily hospitals, physicians, and diagnostic and medical devices companies).

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

First Published: Oct 15 2024 | 5:19 PM IST



Source link

Paras Defence secures arms licence from Govt; share price jumps 5%

Paras Defence secures arms licence from Govt; share price jumps 5%



Shares of aerospace & defense company, Paras Defence and Space Technologies, jumped 5.36 per cent to hit the day’s high of Rs 1118 on the BSE during intra-day deals on Tuesday. The defense company, in a regulatory filing, has informed the exchanges that it has been granted a licence under the Arms Act, 1959, by the Department for Promotion of Industry & Internal Trade, Ministry of Commerce & Industry, Government of India. 


Paras Defence, in the regulatory filing, said, “This licence authorizes the Company to engage in the design, development, manufacturing, assembly, and upgrading of cannons for naval gun systems, air defense gun system, airborne cannon systems (helicopter, fighter jet), armored fighting vehicles based on cannon systems, and mounted cannon systems of caliber – 20X102 MM, 20X110 MM, 20X128 MM, 20X138 MM, 20X139 MM, 23X152 MM, 30X173 MM, 30X165 MM, 30X113 MM, 35X228 MM, and 40X365 MM with a proposed annual capacity of 100 units.”

Click here to connect with us on WhatsApp

 


Paras Defence & Space Technologies provides products and solutions for defense and space applications. The company operates through two business verticals: Optics & Optronic Systems and Defence Engineering. Paras Defence has over 40 years of experience in defense and space engineering. The company’s technologies are used in rocket and missile systems, space research, naval systems, and electronic warfare. Paras Defence has a manufacturing setup with over 600 employees and offers turnkey solutions. The company focuses on technology development, R&D, and delivering quality products on time.


As of October 15, 2024, Paras Defence enjoys a market capitalisation of Rs 4,383.55 crore on the BSE. The defense company is a constituent of the BSE SmallCap index.


Paras Defence shares have declined 24.41 per cent in the last one month, while advancing 58.37 per cent in the last six months. The defense stock has yielded a return of 43.21 per cent year to date. 


The smallcap stock has a 52-week range of Rs 1,592.75 – 608.75 on the BSE.


At around 2:58 PM on Tuesday, Paras Defence shares were quoted trading at Rs 1079.05, up 1.04 per cent from its previous close of Rs 353.85 on the BSE. A combined total of nearly 2.79 lakh shares worth around Rs 30.49 crore exchanged hands on the BSE and NSE.


Meanwhile, the benchmark equity indices, BSE Sensex, and NSE Nifty 50 are trading lower on Tuesday. The Sensex was quoted trading 251.02 points or 0.31 per cent lower at 81,722.03, and Nifty50 at 25,031, down 96.95 points or 0.39 per cent.

First Published: Oct 15 2024 | 3:25 PM IST



Source link